Safety and immunogenicity of a modified vaccinia virus...

  • Main
  • 2020 / 4
  • Safety and immunogenicity of a modified vaccinia virus...

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

Koch, Till, Dahlke, Christine, Fathi, Anahita, Kupke, Alexandra, Krähling, Verena, Okba, Nisreen M A, Halwe, Sandro, Rohde, Cornelius, Eickmann, Markus, Volz, Asisa, Hesterkamp, Thomas, Jambrecina, A
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(20)30248-6
Date:
April, 2020
File:
PDF, 1.39 MB
2020
Conversion to is in progress
Conversion to is failed